Blurbs

Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Merck & Company (MRK) and Teleflex (TFX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Align Tech (ALGNResearch Report), Merck & Company (MRKResearch Report) and Teleflex (TFXResearch Report).

Align Tech (ALGN)

In a report released today, Kevin Caliendo from UBS maintained a Buy rating on Align Tech, with a price target of $370.00. The company’s shares closed last Friday at $276.24, close to its 52-week low of $225.86.

According to TipRanks.com, Caliendo is a 4-star analyst with an average return of 7.0% and a 60.9% success rate. Caliendo covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, AmerisourceBergen, and Johnson & Johnson.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Align Tech with a $343.33 average price target, implying a 23.7% upside from current levels. In a report issued on July 14, Stifel Nicolaus also maintained a Buy rating on the stock with a $375.00 price target.

See today’s best-performing stocks on TipRanks >>

Merck & Company (MRK)

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company, with a price target of $92.00. The company’s shares closed last Friday at $88.98.

According to TipRanks.com, Flynn is a 5-star analyst with an average return of 12.8% and a 62.8% success rate. Flynn covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company, Johnson & Johnson, and Eli Lilly & Co.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merck & Company with a $100.70 average price target.

Teleflex (TFX)

Morgan Stanley analyst Drew Ranieri maintained a Hold rating on Teleflex today and set a price target of $278.00. The company’s shares closed last Friday at $237.22, close to its 52-week low of $235.01.

According to TipRanks.com, Ranieri is a 1-star analyst with an average return of -5.6% and a 46.4% success rate. Ranieri covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Baxter International, and Integra Lifesciences.

Currently, the analyst consensus on Teleflex is a Moderate Buy with an average price target of $303.82, representing a 25.6% upside. In a report released today, Wells Fargo also downgraded the stock to Hold with a $248.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ALGN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos